LightDeck Diagnostics Revenue and Competitors

Boulder, CO USA

Location

$29M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LightDeck Diagnostics's estimated annual revenue is currently $4.3M per year.(i)
  • LightDeck Diagnostics's estimated revenue per employee is $77,500
  • LightDeck Diagnostics's total funding is $29M.

Employee Data

  • LightDeck Diagnostics has 56 Employees.(i)
  • LightDeck Diagnostics grew their employee count by -34% last year.

LightDeck Diagnostics's People

NameTitleEmail/Phone
1
Chief Commercial OfficerReveal Email/Phone
2
Sr. Operations Manager / Oracle NetSuite AdministratorReveal Email/Phone
3
Quality ManagerReveal Email/Phone
4
ScientistReveal Email/Phone
5
Manufacturing TechnicianReveal Email/Phone
6
Principal Software Engineering ConsultantReveal Email/Phone
7
PresidentReveal Email/Phone
8
Document Control SpecialistReveal Email/Phone
9
Manufacturing TechnicianReveal Email/Phone
10
Senior Process EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$2.8M1813%N/AN/A
#3
$70.2M453-1%N/AN/A
#4
$1.6M10-66%N/AN/A
#5
$3.7M24-8%N/AN/A
#6
$2.9M3728%N/AN/A
#7
$3.1M2025%N/AN/A
#8
$2.5M16-20%N/AN/A
#9
$9.1M590%N/AN/A
#10
$4.2M27-7%N/AN/A
Add Company

What Is LightDeck Diagnostics?

MBio Diagnostics is now LightDeck Diagnostics! LightDeck Diagnostics believes in a new approach to healthcare, where fast, accurate, simple, low-cost diagnostic tests will be run wherever and whenever they are needed, without compromise. The company's proprietary LightDeck® platform combines an advanced laser waveguide with novel materials and patented manufacturing techniques to deliver lab-quality results anywhere, in minutes. LightDeck is introducing a portfolio of in vitro diagnostic panels, the first is an on-the-spot test for COVID-19. The LightDeck platform is currently commercialized in veterinary diagnostics and for environmental testing. Learn more at www.LightDeckDx.com Platform Technology The LightDeck platform consists of a robust, portable fluorescence analyzer and disposable, multiplex test cartridges. The LightDeck® platform was designed to meet customer requirements: • Quality: Highly sensitive tests that deliver lab-quality results • Quick: Actionable data in as little as 5 minutes with a simple procedure • Quantitative: More data to inform treatment decisions • Multiplex: Multiple related tests for better precision plus internal quality control to maximize safety The test procedure is simple enough that an untrained user can perform testing almost anywhere. Panels can be configured to run multiple related tests simultaneously to help diagnosis or rule-out a specific condition. Internal quality control runs with every test to ensure quality and not report questionable results.

keywords:N/A

$29M

Total Funding

56

Number of Employees

$4.3M

Revenue (est)

-34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LightDeck Diagnostics News

2022-04-06 - Atonarp Announces Key Additions to the Executive ...

These solutions are now helping patients in cancer diagnosis, ... Most recently, she was Chief Marketing Officer at LightDeck Diagnostics,...

2022-04-06 - Atonarp Announces Key Additions to the Executive ...

These solutions are now helping patients in cancer diagnosis, ... Most recently, she was Chief Marketing Officer at LightDeck Diagnostics,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M56-32%$29M
#2
$11.1M568%N/A
#3
$7.1M56-3%N/A
#4
$7.3M5610%N/A
#5
$13.9M574%N/A